Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jupiter Neurosciences (JUNS) FCF Margin (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed FCF Margin for 2 consecutive years, with 3791.08% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 2278763.0% to 3791.08% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8200.15% through Dec 2025, up 589919.0% year-over-year, with the annual reading at 24838.21% for FY2025, N/A changed from the prior year.
  • FCF Margin for Q4 2025 was 3791.08% at Jupiter Neurosciences, down from 96768.65% in the prior quarter.
  • The five-year high for FCF Margin was 96768.65% in Q3 2025, with the low at 18996.55% in Q4 2024.